Celecoxib sensitizes gastric cancer to rapamycin via inhibition of the Cbl-b-regulated PI3K/Akt pathway.
about
Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literatureCelecoxib prevents pressure overload-induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress.miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells.
P2860
Celecoxib sensitizes gastric cancer to rapamycin via inhibition of the Cbl-b-regulated PI3K/Akt pathway.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Celecoxib sensitizes gastric c ...... -b-regulated PI3K/Akt pathway.
@en
type
label
Celecoxib sensitizes gastric c ...... -b-regulated PI3K/Akt pathway.
@en
prefLabel
Celecoxib sensitizes gastric c ...... -b-regulated PI3K/Akt pathway.
@en
P2093
P2860
P1433
P1476
Celecoxib sensitizes gastric c ...... -b-regulated PI3K/Akt pathway.
@en
P2093
Huachuan Zheng
Jinglei Qu
Xiujuan Qu
Yunpeng Liu
P2860
P2888
P304
P356
10.1007/S13277-015-3232-6
P577
2015-02-21T00:00:00Z
P6179
1032837493